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ABSTRACT
Objectives: Multiple myeloma is the second most
common haematological cancer. A growing body of
literature is emerging that investigates the role physical
activity plays in all stages of multiple myeloma
(prevention and survivorship) and to date no attempt
has been made to collate and understand this
literature. Therefore, this scoping review aims to (1)
outline what is already known about physical activity in
all stages of multiple myeloma (2) map the literature
on physical activity and multiple myeloma and (3)
identify future directions for research.
Design: Scoping Review.
Data Sources: Searches were carried out in May
2015. Searchers were conducted in PubMed, Web of
Science, SPORTdiscus and MEDLINE.
Eligibility criteria for selecting studies: To be
included studies had to report original data, investigate
physical activity per se or physical activity correlates
and multiple myeloma or smouldering multiple
myeloma.
Results: A total of 19 papers received full screening,
5 of these papers were excluded. This review identified
three journal articles relating to the role of physical
activity in the prevention of multiple myeloma, nine
papers were identified in the treatment of multiple
myeloma and two on smouldering multiple myeloma.
Conclusions: The search identified that the literature
surrounding multiple myeloma and physical activity is
very limited. We encourage those designing new
cohort studies to allow for future assessment of
associations between physical activity and onset of
multiple myeloma and smouldering multiple myeloma,
as well as the potential role that physical activity plays
in the progression from smouldering multiple myeloma
to multiple myeloma. Second, we encourage the
design and investigation of gender and treatment-
specific physical activity interventions in patients with
multiple myeloma. Finally, we highlight the need for
more randomised controlled trials to evaluate the
impact of different types, frequencies and intensities of
physical activity on various health parameters in
multiple myeloma survivors.
INTRODUCTION
Multiple myeloma
Multiple myeloma (MM) is the second most
common haematological cancer, resulting
from the accumulation of malignant plasma
cells in the bone marrow.1 MM is responsible
for approximately 1% of all cancer cases
globally and in the UK, and incidence rates
have increased in the UK since the
mid-1970s (http://www.cancerresearchuk.
org). There is no known cure for MM, but
current treatment modalities can control the
disease for prolonged periods. MM is gener-
ally a disease of older adults, and approxi-
mately two-thirds of patients diagnosed are
aged 65 years or more.1 Survival is variable,
but about a third of adult patients with MM
diagnosed in 2010–2011 in England and
Wales are predicted to survive for 10 or more
years (http://www.cancerresearchuk.org).
Recent analyses have shown promising evi-
dence of improved outcomes, likely owing to
increasing use of novel treatment agents
used during initial treatment such as thalido-
mide and bortezomib.2 MM is associated
with a number of complications which
include haematological complications
(anaemia, bone marrow failure, bleeding dis-
orders), bone complications (pathological
fractures, lytic bone lesions, hypercalcaemia
related to excessive bone turnover), renal
insufﬁciency, compromised immune function
and neurological complications (eg, spinal
cord and nerve root compression and cranial
nerve compression, often related to base of
skull lesions).3
Almost all patients with MM will have
had the precursor smouldering multiple
Strengths and limitations of this study
▪ This is the first attempt to collate literature sur-
rounding physical activity and multiple myeloma.
▪ There has been little research on physical activity
for multiple myeloma and even less for smoul-
dering multiple myeloma.
▪ This review has identified several avenues for
new research on multiple myeloma and physical
activity.
▪ This review is limited by a shortage of research.
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myeloma (SMM); SMM is characterised by the presence
of MM cells in the bone marrow and M-proteins in the
blood, but without evidence of organ damage.
Individuals with SMM have a 10–20% risk of developing
MM each year.4 Recent recommendations by the
International Myeloma Working Group (IMWG) identify
a group of patients with SMM who are at a high risk of
progression to MM, for whom systemic therapy is
recommended.
Improved treatments for MM means patients with the
disease are living longer, but with the cumulative burden
of bone disease, compromised immunity and
treatment-related toxicities, that prevent the return to
good quality life. MM survivors often suffer from the
sequelae of bone destruction: persistent deformities,
chronic pain, reduced mobility and physical functioning.
It could be hypothesised that participation in physical
activity may be a beneﬁcial strategy to improve reduced
mobility and physical functioning. Hence there is an
increasing need for non-pharmacological strategies for
the management of this patient group.2
Physical activity and the prevention of cancer
There is evidence from over 100 epidemiological
studies, that routine physical activity is associated with
the reduction in the incidence of some cancers (eg,
breast and lung; see reviews by5 6), there also appears to
be a dose–response relationship,7 that is, the higher the
intensity of routine physical activity the greater the pro-
tective effect against cancer. However, the beneﬁts of
physical activity may vary between cancer type, for
example, a recent meta-analysis on physical activity in
relation to risk of haematological cancer identiﬁed 23
papers and showed non-signiﬁcant associations. When
comparing high versus low physical activity levels, the RR
for non-Hodgkin’s lymphoma was 0.91 (95% CI 0.82 to
1.00), for Hodgkin’s lymphoma it was 0.86 (95% CI 0.58
to 1.26), for leukaemia it was 0.97 (95% CI 0.84 to 1.13)
and for MM it was 0.86 (95% CI 0.68 to 1.09).8
Physical activity and cancer survivors
Focus has also turned to physical activity for cancer sur-
vivors. Physical activity has been shown to be safe and
feasible during cancer treatment and can improve phys-
ical functioning and quality of life, as well as reduce
fatigue.9 A recent meta-analysis of high-quality con-
trolled trials10 identiﬁed the importance of regular par-
ticipation in physical activity for the health of cancer
survivors. The analyses showed that physical activity has
been found to improve aerobic ﬁtness, muscular
strength, functional quality of life and self-esteem, and
reduce anxiety. However, the majority of studies identi-
ﬁed investigated solid tumours and very few investigated
haematological cancers. A number of reviews have also
been carried out on the role of physical activity in the
survival of a number of speciﬁc cancers, including
breast, lung and prostate.11–13 A growing body of litera-
ture is emerging that investigates the role physical
activity plays in all stages of MM (prevention and sur-
vivorship) and to date no attempt has been made to
collate and understand this literature.
Aim
Scoping reviews are relatively novel, compared to other
review types (eg, systematic) and are growing in popular-
ity. Scoping reviews allow the researcher to (1) clarify
working deﬁnitions and conceptual boundaries of a
topic area, (2) outline what is already known and iden-
tify gaps in existing research, and (3) map existing litera-
ture of existing evidence.14 This scoping review aims to
(1) outline what is already known about the role of phys-
ical activity in all stages of MM (2) map the literature on
physical activity and MM and (3) identify future direc-
tions for research.
METHODS AND ANALYSIS
General framework for scoping review and initial search
criteria
The main stages for a scoping review stated in Levac
et al15 were followed (1) Identify the research question,
(2) Identify relevant studies, (3) Study selection, (4)
Charting the data, (5) Collating, summarising and
reporting the results. The initial question was “what is
known about the role of physical activity in all stages of
MM (prevention and survivorship).” Studies including
the MM precursor SMM were included since individuals
have a 10–20% chance of developing MM each year.
Search criteria were then established; in order to
scope and include the majority of literature the exclu-
sion criteria were minimal and included (1) any study
investigating physical functioning and not physical activ-
ity per se (2) non-human studies (3) studies not pub-
lished in English, (4) and studies investigating only the
benign condition Monoclonal Gammopathy of
Undetermined Signiﬁcance (MGUS) (since there is only
a 1% chance a year of developing MM). To be included
studies had to report original data, investigate physical
activity per se or physical activity correlates and MM or
SMM, work published in peer-reviewed academic jour-
nals, PhD dissertations, research reports and full confer-
ence papers were considered. Searchers were conducted
in PubMed, Web of Science, SPORTdiscus and
MEDLINE. MEDLINE and PubMed were both searched
separately as a type of sensitivity analyses for the search
terms, since PubMed is a search engine for MEDLINE;
all papers identiﬁed in PubMed were identiﬁed in
MEDLINE and vice versa. Search terms entered into
each database are presented in table 1. Titles of identi-
ﬁed papers were screened by one reviewer (LS) and
those with titles not deemed relevant were removed.
Remaining papers were then screened by two reviewers
(LS and OM) against the inclusion/exclusion criteria,
no disagreements occurred between reviewers on which
papers to include. Reference lists of remaining papers
after review were then searched to identify papers
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missed in electronic searches, and reference lists of
those papers, and so on until no further papers could
be identiﬁed.
RESULTS
Searches were carried out in May 2015. First the search
engine PubMed was searched and 35 papers were identi-
ﬁed, of which 13 were entered into full-text review. Next,
Web of Science was searched and 134 papers were iden-
tiﬁed, of which an additional four, previously unidenti-
ﬁed papers, were entered into full-text review. We then
searched SPORTdiscuss and MEDLINE combined, 53
papers were identiﬁed and two additional papers (iden-
tiﬁed by SPORTdiscuss) were incorporated. A total of 19
papers were reviewed, 5 of these papers were excluded,
1 paper examined only physical functioning and not
physical activity, another paper did not investigate MM
or SMM per se, 1 paper did not distinguish MM from
other haematological cancers, another was a letter and
one was the reporting of a protocol. Finally, we searched
reference lists of papers and no further studies were
included. A total of 14 papers were included in this
review. See ﬁgure 1 for ﬂow of citations.
The following information was extracted from each
paper: Title, author, year of publication, study design,
study aim and key ﬁndings (tables 2–4). If the informa-
tion was not available from the abstract the appropriate
information was extracted from the full text. Findings
from scoping the literature are presented as stage of
cancer journey (prevention and survivorship). Results
for MM and SMM are reported separately.
Prevention
This review identiﬁed three journal articles relating to
the role of physical activity in the prevention of MM
(table 2). All studies were of a prospective cohort
design with 11,16 15 17 and 22 years 18 follow-up, these
studies produced mixed results. Two studies16 18 found
no associations between baseline physical activity and
incident MM. One study found that for men and
women walking less than 30 min a day at baseline,
compared to walking greater than 30 min a day, was
associated with increased age and sex-adjusted MM risk
(HR=2.0; 95% CI 1.2 to 3.4). 17
Survivorship
Nine papers were identiﬁed that addressed physical
activity during, or after, treatment for MM, of which
three used a qualitative design,19–21 three used a rando-
mised controlled trial (RCT) 22–24 one was a single arm
pilot study,25 and two were cross-sectional26 27 (tables 3
and 4).
The qualitative studies aimed to identify barriers and
facilitators to physical activity in patients with MM.
Barriers to physical activity predominately related to the
symptoms of MM and side effects of therapy, including
pain, fatigue and fear of infection. Low self-motivation
was also a barrier. Women participated in a more diverse
range of physical activities than men and there were
gender differences in preferred type of physical activity.
Women were more likely to report psychological and
social beneﬁts; whereas men reported physical activity as
a way to keep busy and self-motivation was a barrier.
Patients treated with an autologous stem cell transplant
more often reported affective beneﬁts of participation in
physical activity and fatigue as a barrier. Patients treated
with other (non-transplant related) therapies (eg,
chemotherapy, radiotherapy) were more likely to report
pain as a barrier. Commitment to keeping their promise
to exercise helped patients to continue their exercise
Table 1 Search terms
PubMed "multiple myeloma"[MeSH Terms] OR
(“multiple"[All Fields] AND “myeloma"[All
Fields]) OR “multiple myeloma"[All
Fields]) AND (“motor activity"[MeSH
Terms] OR (“motor"[All Fields] AND
“activity"[All Fields]) OR “motor
activity"[All Fields]
Web of
Science
Myeloma and physical activity or exercise
or walking
MEDLINE Multiple myeloma and physical activity or
exercise or walking
SportsDiscuss Multiple myeloma and physical activity or
exercise or walking
Figure 1 Flow chart of citations. MGUS, Monoclonal
Gammopathy of Undetermined Significance.
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programme during times when they were not feeling
well. Encouragement from family and healthcare profes-
sionals was reported to facilitate adherence to an exer-
cise programme. Patients reported needing to reduce
the exercise intensity or take time off from exercise
immediately following chemotherapy.
One cross-sectional study26 aimed to examine the dif-
ferences between prediagnosis and postdiagnosis levels
of physical activity using retrospective recall, perceived
barriers and likelihood of attending a physical activity
programme, and factors that inﬂuence whether or not
respondents are meeting physical activity guidelines.
The study found that signiﬁcantly more people reported
meeting the physical activity guideline of 150 min of
moderate-to-vigorous activity per week prediagnosis than
post. Those who participated in sufﬁcient levels of phys-
ical activity prior to diagnosis were approximately ﬁve
times more likely to meet physical activity guidelines
postdiagnosis, compared to people who did not meet
guidelines prior to diagnosis. Reported perceived bar-
riers to physical activity participation were fatigue, injur-
ies, pain, other health conditions, age-related decline in
physical ability, lack of knowledge on physical activities
that are safe, cost of exercise, nausea, no one to exercise
with and lack of time. The other cross-sectional study
examined the association between physical activity and
quality of life in MM survivors. It was found that 6.8%
and 20.4% of survivors met physical activity guidelines
during active and off treatment periods, respectively.
Participation in physical activity was found to be posi-
tively associated with overall quality of life.27
The single arm pilot study explored the feasibility and
patient outcomes of a tailored, physiotherapist-led exer-
cise programme, consisting of stretching, strength and
resistance, and aerobic exercise, in treated MM survi-
vors.25 This exercise programme was found to be feasible
and safe with no adverse reactions to exercise reported.
Uptake to the exercise programme and attendance rates
were high indicating willingness to engage and strong
adherence to the physical activity intervention. Beneﬁts
were demonstrated in patient reported quality of life
and improvements in upper and lower limb strength.
One RCT aimed to determine the effect of epoetin
therapy with and without a home-based individualised
exercise programme that incorporated stretching,
aerobic and strength resistance training for patients
being treated with high-dose chemotherapy and autolo-
gous peripheral blood stem cell transplantation for
MM.22 The study found that recovery and treatment
response were not signiﬁcantly different between groups
after transplantation. However, the exercise group had
signiﬁcantly fewer red blood cell transfusions and fewer
attempts at stem cell collection. Another RCT 23 aimed
to compare usual care with a home-based individualised
exercise programme, consisting of stretching, strength
and resistance, and aerobic exercise, in patients receiv-
ing intensive treatment for MM and epoetin alfa
therapy. No differences were found between the
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Table 3a Description of qualitative and cross-section studies on physical activity and multiple myeloma survivorship
Author
Year of
publication Study design Study aim Key findings
Craike21 2013 Qualitative semistructure
telephone interview
To gain an in-depth understanding of
the physical activity experiences and
perceived benefits and barriers to
physical activity for patients with MM
▸ Barriers to physical activity predominately related to the symptoms of
MM and side effects of therapy, including pain, fatigue and fear of
infection
▸ Low self-motivation was also a barrier
▸ Women participated in a more diverse range of physical activities than
men and there were gender differences in preferred type of physical
activity
▸ Women were more likely to report psychological and social benefits;
whereas men reported physical activity as a way to keep busy and
self-motivation was a barrier
Coon19 2004 Qualitative—face to face
interviews of intervention
participants in RCT
The aim of this study was to
understand how participants decide
when to start, interrupt, stop or resume
an exercise programme or adjust the
intensity. And to understand what
helped or hindered the participants’
ability to do exercises
▸ Intrinsic factors that facilitated exercise adherence included a belief that
exercise would be beneficial, a personal moral/ethical philosophy with
regard to honouring a commitment and/or taking responsibility for one’s
health, and personal strategies such as keeping a routine and setting
goals
▸ Extrinsic facilitators included having a good support system and
receiving prophylactic epoetin alfa
Coon20 2004 Qualitative interviews—
naturalistic
(constructionists) of
participants taking part in
an exercise programme
To ascertain how patients with MM
appraised the experience of
participating in a home-based exercise
intervention as part of a RCT of
prophylactic epoetin alfa with or without
exercise
▸ Patients with MM can safely carry out a home-based exercise
programme aimed at reducing cancer-related fatigue
▸ Commitment to keeping their promise to exercise helped participants to
continue their exercise programme during times when they were not
feeling well
▸ Encouragement from family and healthcare professionals facilitates
adherence to an exercise programme
▸ Many participants avoided taking time off from exercise because they
had experienced dramatic declines in their strength and stamina after
interruptions to their exercise programme However, most patients
needed to reduce the exercise intensity or take time off from exercise
immediately following chemotherapy
Craike26 2013 Cross-sectional survey,
including retrospective
recall
To examine, for people treated for MM,
(1) differences between prediagnosis
and postdiagnosis levels of physical
activity, (2) perceived barriers and
likelihood of attending a physical
activity programme and (3) factors that
influence whether or not respondents
are meeting physical activity guidelines
▸ Significantly more people were meeting physical activity guidelines
prediagnosis (38.9%) than currently (20.1%)
▸ The strongest perceived barrier was fatigue (37.8%), followed by
injuries (34.2%), pain (28.1%), other health conditions (21.1%) and
age-related decline in physical ability (18.5%). Lack of knowledge about
physical activities that are safe (19.7%), lack of confidence in physical
ability (17.1%) and fear or injury (16.2%) were also reported
▸ Perceived barriers relating to interpersonal factors were least likely to be
reported as barriers to participation, including nausea (7.9%), cost of
exercise (9.2%), no one to exercise with (10.1%), and lack of time
(10.1%)
Continued
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experimental and control groups for fatigue, sleep or
performance (aerobic capacity). However, exercise com-
bined with epoetin alfa helped alleviate anaemia. One
RCT24 included participants receiving high-dose chemo-
therapy and autologous peripheral blood stem cell trans-
plantation and tested the feasibility of home-based
exercise therapy (consisting of similar exercises to those
previously mentioned). The study found that those
assigned to the exercise group experienced a signiﬁcant
increase in lean body weight compared to the non-
exercise group. Moreover, the study suggests that an
exercise programme for patients receiving aggressive
treatment for MM is feasible and may be effective in
decreasing fatigue and mood disturbance while improv-
ing sleep.
Physical activity and SMM
The scoping review identiﬁed just two papers on SMM
and physical activity, both of these were case reports on
the same female patient with SMM. One case study
aimed to document heart rate variability during a
6-week period in a female patient with SMM who was
currently performing a high-intensity training pro-
gramme.28 The patient with SMM recorded similar heart
rate variability to that of six age-matched controls. The
other case study29 aimed to evaluate the inﬂuence of a
training programme on changes in serum monoclonal
protein level, percentage of bone marrow plasma cells,
ﬁtness performance and cardiac autonomic control.
The case study reports that exercise performance in all
ﬁtness components improved while serum monoclonal
protein levels and percentage of bone marrow plasma
cells decreased. Moreover, time and frequency domain
heart rate variability parameters exhibited signiﬁcant
increases with heart rate complexity remaining the
same.
DISCUSION
This scoping review has highlighted that to date there
has been little research on physical activity for MM and
even less for SMM. The literature that does exist on the
role of physical activity in the prevention of MM is
inconclusive and much more epidemiological research
is needed in this area using larger samples and prospect-
ive cohort designs. We encourage those in the process of
designing new cohort studies to allow for future investi-
gation of such longitudinal associations.
This review has identiﬁed numerous suggested social,
sociodemographic and biomedical barriers and facilita-
tors to physical activity in patients with MM. Identiﬁed
barriers and facilitators suggest that gender and
treatment-speciﬁc physical activity interventions may
yield the best results. We recommend that future
research should test this hypothesis. Furthermore, those
who have low levels of physical activity prediagnosis may
beneﬁt the most from physical activity interventions.
More research is needed to investigate the
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Table 3b Description of experimental studies on physical activity and multiple myeloma survivorship
Author
Year of
publication Study design Study aim Key findings
Coleman23 2012 RCT with repeated measures
▸ 15-week intervention period
▸ Intervention consisted of stretching,
strength and resistance, and aerobic
exercise (frequency of exercise
sessions and duration is not reported)
To compare usual care with a home-based
individualised exercise programme (HBIEP) in
patients receiving intensive treatment for MM
and epoetin alfa therapy
▸ No statistically significant differences
existed among the experimental and
control groups for fatigue, sleep or
performance (aerobic capacity) (p>0.05)
▸ Exercise combined with epoetin alfa
helped alleviate anaemia
Coleman22 2008 RCT
▸ 15-week intervention period
▸ Intervention consisted of stretching,
strength and resistance, and aerobic
exercise (frequency of exercise
session and duration is not reported)
To determine the effect of epoetin therapy (short
term vs long term) with and without a
home-based individualised exercise programme
that incorporated aerobic and strength
resistance training for patients being treated with
high-dose chemotherapy and autologous
peripheral-blood stem cell transplantation for
MM
▸ Recovery and treatment response were
not significantly different between groups
after transplantation
▸ The exercise group had significantly fewer
red blood cell transfusions and fewer
attempts at stem cell collection (p<0.025)
▸ Serious adverse events were similar in
each group (p>0.05)
Coleman24 2003 RCT
▸ Intervention period, session frequency
and duration is not reported
▸ Intervention consisted of stretching,
strength and resistance, and aerobic
exercise
To test the feasibility of home-based exercise
therapy for patients receiving high-dose
chemotherapy and autologous peripheral blood
stem cell transplantation as treatment for MM
▸ Individuals assigned to exercise gained an
average lean body weight of 0.40 kg per
month
▸ The non-exercise group experienced and
average decline in lean body weight of
−0.44 kg/month (p<0.01)
▸ The study suggests that an exercise
programme for patients receiving
aggressive treatment for MM is feasible
and may be effective in decreasing fatigue
and mood disturbance while improving
sleep
Groeneveldt25 2013 Single arm pilot study
▸ 6-month intervention period
▸ Intervention consisted of taking part in
stretching, strength and resistance,
and aerobic exercise three times a
week
To assess the feasibility (accrual rate,
acceptability and adherence) and safety of an
exercise programme for MM survivors
▸ The exercise programme was feasible and
safe for patients with MM and there was
high attendance and acceptability
▸ Benefits were evident in patients reported
outcomes of QOL, fatigue and measured
muscle strength (all p<0.01)
RCT, randomised controlled trial; QOL, quality of life.
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generalisability of the identiﬁed barriers and facilitators
to other populations of patients with MM, and longitu-
dinal studies to address associations are encouraged.
There is limited evidence using RCTs to evaluate the
impact of physical activity on health parameters in
patients with MM during and after treatment, although
it appears to be safe and accepted by patients. Existing
evidence from RCTs suggests physical activity may aid in
various MM treatments and alleviate some comorbid-
ities. When reviewing the literature one protocol of an
ongoing study was identiﬁed that aims to determine the
effectiveness of an individualised high-intensity strength
and interval training programme with respect to physio-
logical and psychological status in patients with MM,
who have recently undergone high-dose chemotherapy
followed by autologous stem cell transplantation, using a
RCT.30 Future research should include RCTs to evaluate
the impact of different types, frequencies and intensities
of physical activity (eg, aerobic or anaerobic) on various
health parameters in patients with MM (eg, fatigue,
quality of life, sarcopenic obesity, bone health and
anaemia). Of speciﬁc interest may be the effect of phys-
ical activity on the toxicities experienced by patients
receiving anti-MM therapies, as well as the effect of par-
ticular drugs or treatment regimens on levels of physical
activity. Such questions will become increasingly import-
ant with the improved survival of patients with MM, and
the trend towards extended therapy. However, it should
be noted that one important concern with MM in
regard to physical activity is the fracture risk related to
bone lesions. A fracture risk assessment should be
carried out on a patient with MM prior to being given
permission to be physically active. This has been per-
formed in the past using radiographs in combination
with Mirel’s score. For example, in a recent study by
Groeneveldt et al, radiographs were assessed for fracture
risk by a multidisciplinary team of musculoskeletal radi-
ologist, clinical oncologist, myeloma specialists, physio-
therapist and clinical nurse specialists. Patients
considered to be at risk of fractures, for example, with
large lytic lesions of the long bones or extensive lytic
disease in the pelvis, underwent cross-sectional imaging
with CT or MRI and were referred for surgery and/or
radiotherapy. Those not at risk were recommended for
exercise, while some of those at risk underwent surgical
ﬁxation before embarking on the exercise programme.25
Only two studies were identiﬁed in the area of SMM
and physical activity. However, inferences should not be
drawn from two case studies on a single patient with
SMM. This is an understudied research area and one
that requires epidemiological investigation.
This is the ﬁrst review of literature on physical activity
and MM and SMM. The variety of search databases uti-
lised, as well as extensive reference searches, reduced
the risk of bias. However, there is a potential inﬂuence
of publication bias, with negative and null ﬁndings
remaining in the ‘ﬁle drawer.’ This review is limited by a
shortage of research and it should be noted that further
data may exist. This review did not include studies in
which MM was pooled with other haematological
cancers.31 32 Moreover, the use of additional search
terms may have identiﬁed other relevant papers.
CONCLUSION
The literature surrounding MM and SMM and physical
activity is limited. Much more research is needed in all
areas of MM and SMM and physical activity to
Table 4 Description of studies on physical activity and smouldering multiple myeloma
Author
Year of
publication
Study
design Study aim Key findings
Boullosa28 2010 Case
Report
To document heart rate variability (HRV)
during a 6-week period in a female SMM
patient that was currently performing a
high-intensity training programme
▸ The major finding was the reported similar
HRV for a highly physically active young
SMM patient to that of age-matched
controls
Boullosa29 2013 Case
Report
To evaluate the influence of a
supervised training programme on the
changes in serum monoclonal protein
level (ie, IgG), percentage of bone
marrow plasma cells (BMPCs), fitness
performance and cardiac autonomic
control (ie, HR variability (HRV) and HR
complexity (HRC) in a female diagnosed
with SMM
▸ Exercise performance in all fitness
components was improved while IgG
levels and BMPCs decreased from 20%
to 10%, respectively
▸ Time and frequency domain HRV
parameters exhibited significant increases
(18%–29%) with HRC remaining
unchanged
▸ The current case report results indicated
that a multimodal training programme
designed for the development of various
physical capacities improved exercise
performance, haematological function and
cardiac autonomic control that may
improve long-term prognosis for SMM
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understand the true beneﬁt of physical activity for this
population. We encourage those in the process of
designing new cohort studies to allow for future assess-
ment of associations between physical activity and onset
MM and SMM, as well as the potential role physical activ-
ity plays in the transition from SMM to MM. Second, we
encourage the design and investigation of gender and
treatment-speciﬁc physical activity interventions in
patients with MM. Finally, we highlight the need for
more RCTs to evaluate the impact of different types, fre-
quencies and intensities of physical activity on various
health parameters in patients with MM.
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